- BrainStorm Cell Therapeutics' (BCLI) NurOwn adult stem cells helped a patient with Lou Gehrig's Disease and myasthenia gravis (MG) show significant improvement in cognition, speech, and muscle power a month after treatment.
- After six months, the patient's symptoms had worsened again but improved when he was given another injection of NurOwn.
- "The results suggest that repeated therapy may maintain and enhance the clinical benefits of NurOwn cell therapy in neurological diseases," a case report that is being published in "Muscle & Nerve" says.
- BrainStorm expects to finalize a Phase IIa clinical trial in H1.
- Shares are +5.6%. (PR)